Milmed Unico AB
559163-1741ActiveEarly-stage developer of patented medicinal probiotics for chronic diseases.
Biotechnology and Pharmaceutical Development Companymilmedunico.com
Yleiskatsaus
- 1
- Työntekijät
- 78t SEK
- Liikevaihto
- 2018
- Perustettu
Avainpäättäjät
Johan Olsson
Board Member
Anna Linton
Board Member
Thomas Lenz
CEO
Tatiana Blomqvist
Production and Lab Manager
+8 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Milmed Unico AB is an early-stage biotechnology company focused on developing groundbreaking medicinal probiotics. Their core technology is based on a patented, non-toxic yeast culture that has shown positive impacts on living cells. The company holds patent protection for treatments targeting three...
IMMUNEBIOTECH MEDICAL NORWAY NUF